These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23436807)

  • 21. Preclinical testing of a broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic.
    Hashemi MM; Rovig J; Bateman J; Holden BS; Modelzelewski T; Gueorguieva I; von Dyck M; Bracken R; Genberg C; Deng S; Savage PB
    J Antimicrob Chemother; 2018 Jan; 73(1):143-150. PubMed ID: 29029265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of ceragenins for prevention of bacterial colonization of hydrogel contact lenses.
    Gu X; Jennings JD; Snarr J; Chaudhary V; Pollard JE; Savage PB
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6217-23. PubMed ID: 23970466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.
    Leszczyńska K; Namiot A; Cruz K; Byfield FJ; Won E; Mendez G; Sokołowski W; Savage PB; Bucki R; Janmey PA
    J Appl Microbiol; 2011 Jan; 110(1):229-38. PubMed ID: 20961363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms.
    Du J; Bandara HM; Du P; Huang H; Hoang K; Nguyen D; Mogarala SV; Smyth HD
    Mol Pharm; 2015 May; 12(5):1544-53. PubMed ID: 25793309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antimicrobial agent, Next-Science, inhibits the development of Staphylococcus aureus and Pseudomonas aeruginosa biofilms on tympanostomy tubes.
    Banerjee D; Tran PL; Colmer-Hamood JA; Wang JC; Myntti M; Cordero J; Hamood AN
    Int J Pediatr Otorhinolaryngol; 2015 Nov; 79(11):1909-14. PubMed ID: 26388185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
    Pompilio A; Crocetta V; Scocchi M; Pomponio S; Di Vincenzo V; Mardirossian M; Gherardi G; Fiscarelli E; Dicuonzo G; Gennaro R; Di Bonaventura G
    BMC Microbiol; 2012 Jul; 12():145. PubMed ID: 22823964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meloxicam inhibits biofilm formation and enhances antimicrobial agents efficacy by Pseudomonas aeruginosa.
    She P; Wang Y; Luo Z; Chen L; Tan R; Wang Y; Wu Y
    Microbiologyopen; 2018 Feb; 7(1):. PubMed ID: 29178590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of biofilm inhibition and degradation by antimicrobial peptides.
    Segev-Zarko L; Saar-Dover R; Brumfeld V; Mangoni ML; Shai Y
    Biochem J; 2015 Jun; 468(2):259-70. PubMed ID: 25761937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial peptides prevent bacterial biofilm formation on the surface of polymethylmethacrylate bone cement.
    Volejníková A; Melicherčík P; Nešuta O; Vaňková E; Bednárová L; Rybáček J; Čeřovský V
    J Med Microbiol; 2019 Jun; 68(6):961-972. PubMed ID: 31107198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Biofilm Effects of Synthetic Antimicrobial Peptides Against Drug-Resistant
    Park SC; Lee MY; Kim JY; Kim H; Jung M; Shin MK; Lee WK; Cheong GW; Lee JR; Jang MK
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31842508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
    PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.
    Maisetta G; Grassi L; Esin S; Serra I; Scorciapino MA; Rinaldi AC; Batoni G
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926942
    [No Abstract]   [Full Text] [Related]  

  • 34. Ceragenin-mediated disruption of Pseudomonas aeruginosa biofilms.
    Wnorowska U; Łysik D; Piktel E; Zakrzewska M; Okła S; Lesiak A; Spałek J; Mystkowska J; Savage PB; Janmey P; Fiedoruk K; Bucki R
    PLoS One; 2024; 19(2):e0298112. PubMed ID: 38346040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 36. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
    Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of Antibiotics against Pseudomonas aeruginosa in an
    Diaz Iglesias Y; Van Bambeke F
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015047
    [No Abstract]   [Full Text] [Related]  

  • 38. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
    Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients.
    Fricks-Lima J; Hendrickson CM; Allgaier M; Zhuo H; Wiener-Kronish JP; Lynch SV; Yang K
    Int J Antimicrob Agents; 2011 Apr; 37(4):309-15. PubMed ID: 21382698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.